Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NYKØBING F. DYREHOSPITAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.5% 3.3% 3.7% 3.4% 3.8% 2.6% 11.7% 11.7%   Credit score (0-100)   54 54 50 53 50 62 21 21   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,595 6,089 6,385 6,952 7,752 8,302 0.0 0.0   EBITDA   1,284 1,593 1,067 1,236 1,198 1,654 0.0 0.0   EBIT   1,097 1,405 888 1,074 1,055 1,513 0.0 0.0   Pre-tax profit (PTP)   1,092.3 1,392.8 875.7 1,057.3 1,052.8 1,504.6 0.0 0.0   Net earnings   853.8 1,086.5 681.3 820.8 817.8 1,247.6 0.0 0.0   Pre-tax profit without non-rec. items   1,092 1,393 876 1,057 1,053 1,505 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   2,174 1,986 1,807 1,645 1,897 330 0.0 0.0   Shareholders equity total   2,105 2,542 2,136 2,276 2,494 2,741 2,486 2,486   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 500 0.0 0.0   Balance sheet total (assets)   3,556 4,572 3,676 3,534 3,819 5,042 2,486 2,486   Net Debt   -547 -1,895 -1,191 -1,171 -835 -3,190 -2,486 -2,486     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,595 6,089 6,385 6,952 7,752 8,302 0.0 0.0   Gross profit growth   13.2% 8.8% 4.9% 8.9% 11.5% 7.1% -100.0% 0.0%   Employees   10 9 10 11 12 11 0 0   Employee growth %   0.0% -10.0% 11.1% 10.0% 9.1% -8.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,556 4,572 3,676 3,534 3,819 5,042 2,486 2,486   Balance sheet change%   21.6% 28.5% -19.6% -3.9% 8.1% 32.0% -50.7% 0.0%   Added value   1,283.9 1,592.6 1,066.6 1,236.1 1,217.5 1,653.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -38 -375 -358 -324 109 -1,709 -330 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.6% 23.1% 13.9% 15.4% 13.6% 18.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   34.3% 34.5% 21.5% 29.6% 28.7% 34.2% 0.0% 0.0%   ROI %   52.8% 54.5% 34.5% 43.9% 40.4% 50.7% 0.0% 0.0%   ROE %   46.8% 46.8% 29.1% 37.2% 34.3% 47.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   59.2% 55.6% 58.1% 64.4% 65.3% 54.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -42.6% -119.0% -111.7% -94.7% -69.7% -192.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 18.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   49.2% 0.0% 0.0% 0.0% 0.0% 3.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.6 1.2 1.1 1.5 1.1 1.7 0.0 0.0   Current Ratio   1.2 1.4 1.4 1.8 1.7 2.1 0.0 0.0   Cash and cash equivalent   546.6 1,895.4 1,191.1 1,171.2 835.4 3,690.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   185.3 798.4 561.5 855.6 820.8 2,421.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   128 177 107 112 101 150 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   128 177 107 112 100 150 0 0   EBIT / employee   110 156 89 98 88 138 0 0   Net earnings / employee   85 121 68 75 68 113 0 0